The Emerging Role of Molecular Testing in an Era of Precision Medicine - Ovarian Cancer

An online panel discussion with leading experts knowledgeable about the importance of utilizing molecular testing in the diagnosis of cancer patients, including issues and perspectives from various stakeholders on molecular testing and next-generation sequencing. The education will also include individual patient-focused cases, which will give clinicians in oncology an opportunity to put into practice what they have learned and to further enhance their subject matter understanding, as well as to allow them to interact directly with clinical content experts.

This activity is supported by an educational grant from AstraZeneca

Moderator

Patrick Kiel, PharmD
Indiana University, Indianapolis, IN

Faculty

Jeanne Schilder, MD
Indiana University, Indianapolis, IN

Faculty

Courtney Cortez, NP
Indiana University, Indianapolis, IN

Faculty

Cynthia Hunter, MS, CGC
Indiana University, Indianapolis, IN

 

The Emerging Role of Molecular Testing in an Era of Precision Medicine - Ovarian Cancer

Patrick Kiel, PharmD
Indiana University, Indianapolis, IN

Posted: 10/12/2017
Expires: 10/12/2018

Credits/Contact Hours: 1.0

Access the Activity for Credit*
   
Participate Without Claiming Credit

* This link will take you to the
Educational Measures website.

These CME/CE/CPE certified activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.